JP Stock MarketDetailed Quotes

5201 AGC

Watchlist

4648.0
-35.0-0.75%

20min DelayMarket Closed Dec 16 15:30 JST

1.01TMarket Cap15.29P/E (Static)

AGC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AGC Q3 2024 Earnings Date

Currency：JPYNov 1, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	519.03B	--
		+4.12%
EPS	--	7.64	--
		-51.87%

Analyst Rating

Buy

Dec 11, 2024

AGC Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 518.100B	--
--	2024/Q4	-- / 562.038B	--
Nov 1, 2024	2024/Q3	519.005B / 518.554B	--
Aug 1, 2024	2024/Q2	516.455B / 525.230B	--
May 8, 2024	2024/Q1	498.740B / 451.750B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 518.100B--

--2024/Q4-- / 562.038B--

Nov 1, 20242024/Q3519.005B / 518.554B--

Aug 1, 20242024/Q2516.455B / 525.230B--

May 8, 20242024/Q1498.740B / 451.750B--

Unlock Free Earnings Estimates

Open Account

AGC Earnings Reports

AGC: Results briefing materials for the 3rd quarter of the fiscal year ending 2024/12

Nov 1 12:00

AGC: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)

Nov 1 12:00

AGC: Confirmation letter

Aug 5 13:03

AGC: Half Year Report - 100th Term (2024/01/01 - 2024/12/31)

Aug 5 13:02

Symbol Price % Chg

D. Western Therapeutics Institute

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 11, 2024

Buy

Strong Buy

30.00%
Buy

10.00%
Hold

60.00%
Underperform

0.00%
Sell

0.00%

Price Target

No Data